TAP Stock Analysis: Molson Coors Brewing | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 6.703m USD | 12M Return: -17.2% | US60871R2094 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 139M
EPS Trend: -49.8%
Qual. Beats: 0
Rev. Trend: -84.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Molson Coors Beverage Company is a global beverage producer that manufactures, markets, distributes, and sells beer and other malt beverage products across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates a tiered brand portfolio spanning above-premium, premium, and economy price points, with flagship brands including Coors Light, Miller Lite, Molson Canadian, Blue Moon, Corona Extra, Stella Artois, Peroni Nastro Azzurro, Becks, and Pilsner Urquell.
Beyond traditional beer, the company has expanded into adjacent beverage categories such as hard seltzers (Topo Chico Hard Seltzer, Vizzy), craft beer, spirits (Blue Run Spirits), cider (Aspall, Rekorderlig), ready-to-drink beverages, premium mixers (Fever-Tree), and energy drinks (ZOA Energy). Originally founded in 1774 and headquartered in Golden, Colorado, the company rebranded from Molson Coors Brewing Company to Molson Coors Beverage Company in January 2020 to reflect its broader product diversification beyond beer. As a major player in the Brewers sub-industry of Consumer Staples, Molson Coors relies on a brand-licensing and distribution model, including partnerships with other major brewers such as Heineken, to extend its global reach.
- US beer volume declines amid shifting consumer preferences toward spirits and RTDs
- Input cost inflation and aluminum pricing pressure gross margins
- Premium portfolio expansion with ZOA Energy and Fever-Tree mixers diversifies revenue
| Net Income: -2.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.86 > 1.0 |
| NWC/Revenue: -5.67% < 20% (prev -1.46%; Δ -4.21% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.98b > Net Income -2.31b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (187.7m) vs 12m ago -6.71% < -2% |
| Gross Margin: 36.22% > 18% (prev 38.75%; Δ -2.54% > 0.5%) |
| Asset Turnover: 43.31% > 50% (prev 42.06%; Δ 1.25% > 0%) |
| Interest Coverage Ratio: -11.44 > 6 (EBIT TTM -2.58b / Interest Expense TTM 225.6m) |
| A: -0.03 (Total Current Assets 4.58b - Total Current Liabilities 5.21b) / Total Assets 24.4b |
| B: 0.24 (Retained Earnings 5.93b / Total Assets 24.4b) |
| C: -0.10 (EBIT TTM -2.58b / Avg Total Assets 25.6b) |
| D: 0.73 (Book Value of Equity 10.1b / Total Liabilities 14.0b) |
| Altman-Z'' = 0.71 = B |
| DSRI: 1.04 (Receivables 1.18b/1.16b, Revenue 11.1b/11.3b) |
| GMI: 1.07 (GM 38.75% / 36.22%) |
| AQI: 0.87 (AQ_t 0.62 / AQ_t-1 0.71) |
| SGI: 0.98 (Revenue 11.1b / 11.3b) |
| TATA: -0.18 (NI -2.31b - CFO 1.98b) / TA 24.4b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of September 29, 2026, the stock is trading at USD 36.27 with a total of 4,145,659 shares traded. Over the past week, the price has changed by -3.43%, over one month by -12.52%, over three months by -7.69% and over the past year by -17.16%.
Current recommended Stop Loss: 34.70 (which is 4.3% or 1.5 ATR below the current price).
Molson Coors Brewing has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold TAP.
- StrongBuy: 4
- Buy: 4
- Hold: 14
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 45.2 | 24.7% |
P/E Forward = 6.7797
P/S = 0.6048
P/B = 0.6795
P/EG = 3.9244
Revenue TTM = 11.1b USD
EBIT TTM = -2.58b USD
EBITDA TTM = -1.83b USD
Long Term Debt = 5.67b USD (from longTermDebt, last quarter)
Short Term Debt = 2.04b USD (from shortTermDebt, last quarter)
Debt = 7.76b USD (from shortLongTermDebtTotal, last quarter) + Leases 52.8m
Net Debt = 5.63b USD (calculated: Debt 7.76b - CCE 2.13b)
Enterprise Value = 12.3b USD (6.70b + Debt 7.76b - CCE 2.13b)
Interest Coverage Ratio = -11.44 (Ebit TTM -2.58b / Interest Expense TTM 225.6m)
EV/FCF = 9.30x (Enterprise Value 12.3b / FCF TTM 1.33b)
FCF Yield = 10.75% (FCF TTM 1.33b / Enterprise Value 12.3b)
FCF Margin = 11.96% (FCF TTM 1.33b / Revenue TTM 11.1b)
Net Margin = -20.81% (Net Income TTM -2.31b / Revenue TTM 11.1b)
Gross Margin = 36.22% ((Revenue TTM 11.1b - Cost of Revenue TTM 7.07b) / Revenue TTM)
Gross Margin QoQ = 34.34% (prev 38.16%)
Tobins Q-Ratio = 0.51 (Enterprise Value 12.3b / Total Assets 24.4b)
Interest Expense / Debt = 2.91% (Interest Expense 225.6m / Debt 7.76b)
Taxrate = 21.72% (61.5m / 283.1m)
NOPAT = -2.02b (EBIT -2.58b * (1 - 21.72%)) [loss with tax shield]
Current Ratio = 0.88 (Total Current Assets 4.58b / Total Current Liabilities 5.21b)
Debt / Equity = 0.77 (Debt 7.76b / totalStockholderEquity, last quarter 10.1b)
Debt / EBITDA = -3.07 (negative EBITDA) (Net Debt 5.63b / EBITDA -1.83b)
Debt / FCF = 4.25 (Net Debt 5.63b / FCF TTM 1.33b)
Total Stockholder Equity = 10.2b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.01% (Net Income -2.31b / Total Assets 24.4b)
RoE = -22.65% (Net Income TTM -2.31b / Total Stockholder Equity 10.2b)
RoCE = -16.28% (EBIT -2.58b / Capital Employed (Equity 10.2b + L.T.Debt 5.67b))
RoIC = -9.80% (negative operating profit) (NOPAT -2.02b / Invested Capital 20.6b)
WACC = 3.86% (E(6.70b)/V(14.5b) * Re(5.69%) + D(7.76b)/V(14.5b) * Rd(2.91%) * (1-Tc(0.22)))
Discount Rate = 5.69% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.20 | Cagr: -5.70%
[DCF] Terminal Value 77.97% ; FCFF base≈1.18b ; Y1≈1.35b ; Y5≈1.99b
[DCF] Fair Price = 139.7 (EV 30.0b - Net Debt 5.63b = Equity 24.3b / Shares 174.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -49.76 | EPS CAGR: -2.56% | SUE: 0.37 | # QB: 0
Revenue Correlation: -84.35 | Revenue CAGR: -2.46% | SUE: 0.09 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.47 | Chg30d=-0.71% | Revisions=-56% | Analysts=16
EPS current Year (2026-12-31): EPS=4.72 | Chg30d=-0.69% | Revisions=+23% | GrowthEPS=-12.9% | GrowthRev=-0.7%
EPS next Year (2027-12-31): EPS=4.89 | Chg30d=-0.42% | Revisions=-35% | GrowthEPS=+3.6% | GrowthRev=+0.1%
[Analyst] Revisions Ratio: -22% (up=20, down=32)